NEWS
Equillium Announces Positive Topline Data From Phase 2 Study of EQ101 in Alopecia Areata
Equillium Inc: EQ101 Was Well Tolerated in Subjects With Alopecia Areata With No Serious Adverse Events Reported
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
Salmon Klein : did you get in? hopefully not at the top
Jaguar8OP Salmon Klein: No
Salmon Klein Jaguar8OP: it's going to drop more at open and then increase, I guess
Jaguar8OP Salmon Klein: I can’t say. Depends on buy side
Salmon Klein Jaguar8OP: now shorts are controlling the price...but they should cover some, they drop the price 60%...no bad